PubMed:33166694 / 911-1006
Annnotations
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T9 | 4-7 | Chemical | denotes | PEP | http://purl.obolibrary.org/obo/CHEBI_18021|http://purl.obolibrary.org/obo/CHEBI_44897 |
| T11 | 8-13 | Chemical | denotes | group | http://purl.obolibrary.org/obo/CHEBI_24433 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 53 | 4-7 | Gene | denotes | PEP | Gene:5550 |
| 54 | 30-33 | Chemical | denotes | HCQ | MESH:D006886 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 0-95 | Sentence | denotes | The PEP group received tablet HCQ 800 mg on day one followed by 400 mg once weekly for 3 weeks. |